Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Nature ; 622(7981): 164-172, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37674082

RESUMEN

Development of immunocompetent T cells in the thymus is required for effective defence against all types of pathogens, including viruses, bacteria and fungi. To this end, T cells undergo a very strict educational program in the thymus, during which both non-functional and self-reactive T cell clones are eliminated by means of positive and negative selection1.Thymic epithelial cells (TECs) have an indispensable role in these processes, and previous studies have shown the notable heterogeneity of these cells2-7. Here, using multiomic analysis, we provide further insights into the functional and developmental diversity of TECs in mice, and reveal a detailed atlas of the TEC compartment according to cell transcriptional states and chromatin landscapes. Our analysis highlights unconventional TEC subsets that are similar to functionally well-defined parenchymal populations, including endocrine cells, microfold cells and myocytes. By focusing on the endocrine and microfold TEC populations, we show that endocrine TECs require Insm1 for their development and are crucial to maintaining thymus cellularity in a ghrelin-dependent manner; by contrast, microfold TECs require Spib for their development and are essential for the generation of thymic IgA+ plasma cells. Collectively, our study reveals that medullary TECs have the potential to differentiate into various types of molecularly distinct and functionally defined cells, which not only contribute to the induction of central tolerance, but also regulate the homeostasis of other thymus-resident populations.


Asunto(s)
Autotolerancia , Linfocitos T , Timo , Animales , Ratones , Diferenciación Celular , Células Epiteliales/citología , Células Epiteliales/metabolismo , Autotolerancia/inmunología , Autotolerancia/fisiología , Linfocitos T/clasificación , Linfocitos T/citología , Linfocitos T/inmunología , Timo/citología , Timo/inmunología , Tejido Parenquimatoso , Células Musculares , Células Endocrinas , Cromatina , Transcripción Genética , Ghrelina
2.
Nature ; 624(7992): 653-662, 2023 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-37993717

RESUMEN

Ameloblasts are specialized epithelial cells in the jaw that have an indispensable role in tooth enamel formation-amelogenesis1. Amelogenesis depends on multiple ameloblast-derived proteins that function as a scaffold for hydroxyapatite crystals. The loss of function of ameloblast-derived proteins results in a group of rare congenital disorders called amelogenesis imperfecta2. Defects in enamel formation are also found in patients with autoimmune polyglandular syndrome type-1 (APS-1), caused by AIRE deficiency3,4, and in patients diagnosed with coeliac disease5-7. However, the underlying mechanisms remain unclear. Here we show that the vast majority of patients with APS-1 and coeliac disease develop autoantibodies (mostly of the IgA isotype) against ameloblast-specific proteins, the expression of which is induced by AIRE in the thymus. This in turn results in a breakdown of central tolerance, and subsequent generation of corresponding autoantibodies that interfere with enamel formation. However, in coeliac disease, the generation of such autoantibodies seems to be driven by a breakdown of peripheral tolerance to intestinal antigens that are also expressed in enamel tissue. Both conditions are examples of a previously unidentified type of IgA-dependent autoimmune disorder that we collectively name autoimmune amelogenesis imperfecta.


Asunto(s)
Amelogénesis Imperfecta , Autoanticuerpos , Enfermedad Celíaca , Poliendocrinopatías Autoinmunes , Humanos , Amelogénesis Imperfecta/complicaciones , Amelogénesis Imperfecta/inmunología , Autoanticuerpos/inmunología , Enfermedad Celíaca/complicaciones , Enfermedad Celíaca/inmunología , Inmunoglobulina A/inmunología , Poliendocrinopatías Autoinmunes/complicaciones , Poliendocrinopatías Autoinmunes/inmunología , Proteínas/inmunología , Proteínas/metabolismo , Ameloblastos/metabolismo , Esmalte Dental/inmunología , Esmalte Dental/metabolismo , Proteína AIRE/deficiencia , Antígenos/inmunología , Antígenos/metabolismo , Intestinos/inmunología , Intestinos/metabolismo
4.
Sci Immunol ; 9(91): eabq6930, 2024 Jan 12.
Artículo en Inglés | MEDLINE | ID: mdl-38215193

RESUMEN

The thymus is a primary lymphoid organ that is essential for the establishment of adaptive immunity through generation of immunocompetent T cells. In response to various stress signals, the thymus undergoes acute but reversible involution. However, the mechanisms governing its recovery are incompletely understood. Here, we used a dexamethasone-induced acute thymic involution mouse model to investigate how thymic hematopoietic cells (excluding T cells) contribute to thymic regeneration. scRNA-seq analysis revealed marked transcriptional and cellular changes in various thymic populations and highlighted thymus-resident innate lymphoid cells type 2 (ILC2) as a key cell type involved in the response to damage. We identified that ILC2 are activated by the alarmins IL-25 and IL-33 produced in response to tissue damage by thymic tuft cells and fibroblasts, respectively. Moreover, using mouse models deficient in either tuft cells and/or IL-33, we found that these alarmins are required for effective thymus regeneration after dexamethasone-induced damage. We also demonstrate that upon their damage-dependent activation, thymic ILC2 produce several effector molecules linked to tissue regeneration, such as amphiregulin and IL-13, which in turn promote thymic epithelial cell differentiation. Collectively, our study elucidates a previously undescribed role for thymic tuft cells and fibroblasts in thymus regeneration through activation of the type 2 immune response.


Asunto(s)
Inmunidad Innata , Interleucina-33 , Ratones , Animales , Linfocitos , Células en Penacho , Alarminas , Modelos Animales de Enfermedad , Fibroblastos , Dexametasona/farmacología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA